Streetbeat News

Stock Prices

CTSH

Cognizant Tech Solns (NASDAQ:CTSH) has outperformed the market over the past 20 years, producing an average annual return of 15.62%. If an investor had bought $100 of CTSH stock 20 years ago, it would be worth $1,766.41 today. The company currently has a market capitalization of $33.15 billion.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 8:00 pm

MTB

M&T Bank (NYSE:MTB) has received various analyst ratings in the last quarter, with 3 bullish, 4 somewhat bullish, and 4 indifferent. The average 12-month price target for the bank, according to 11 analysts, is $149.18, up 1.41% from the previous average of $147.11.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 8:00 pm

CTAS

Cintas (NASDAQ:CTAS) has outperformed the market over the past 10 years by 15.86% on an annualized basis, producing an average annual return of 25.99%. If an investor had bought $100 of CTAS stock 10 years ago, it would be worth $1,016.97 today.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 8:00 pm

AMZN

BIIB

MSFT

TSLA

UPS

The June jobs report showed mixed data, with unemployment dropping to 3.6% but job additions falling short of expectations. Traders are expecting a Fed interest rate hike in July, but weaker job market numbers decrease the likelihood of a consecutive hike in September. The ongoing US-China spat is affecting the semiconductor sector, with new restrictions and bans affecting companies like Amazon and Microsoft. The FDA approved a new Alzheimer's drug by Eisai Co and Biogen. UPS is facing potential labor issues, and Tesla reported strong Q2 deliveries. Earnings reports from several major companies are expected next week.

Portfolio Pulse from Natan Ponieman

July 07, 2023 | 7:52 pm

SPY

The market on close imbalance is leaning towards the sell side with $3.1 billion. This could potentially impact the overall market sentiment and the SPY ETF.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 7:52 pm

ABBV

A significant investor has taken a bearish stance on AbbVie (NYSE:ABBV), with 72% of recent trades being bearish and 27% bullish. The total amount for put options is $676,670 and for call options is $321,586. The targeted price range for AbbVie over the last 3 months is from $100.0 to $165.0. The current price of ABBV is down -1.01% at $135.86. Next earnings are expected in 20 days.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 7:48 pm

BLL

Ball Corporation's shares are trading higher following a report that private equity firms are competing with defense companies to acquire the company's aerospace business.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 7:44 pm

ITA

White House National Security Advisor Jake Sullivan outlined the objectives of President Joe Biden's upcoming Europe trip, emphasizing the importance of a strong NATO and the US's commitment to Ukraine. Sullivan also discussed the evolving threat posed by Belarus and potential deployment of nuclear weapons in the region. He expressed confidence in Sweden's future NATO membership. The iShares U.S. Aerospace & Defense ETF (NYSE:ITA), which offers exposure to defense-related stocks, was 0.3% higher on Friday.

Portfolio Pulse from Piero Cingari

July 07, 2023 | 7:44 pm

COST

Costco's shares are trading lower after the company reported its June sales results.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 7:43 pm

PLUG

Plug Power shares are trading higher due to overall market strength and optimism in the EV sector following recent delivery results. Citigroup has initiated coverage on the stock with a Buy rating.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 7:40 pm